Pancreatic Cancer Research

ResearcherRoswell Park Comprehensive Cancer CenterActive in the last 2 years

Kathryn E. Maraszek

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6280-0324; OpenAlex author ID A5023667010. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 4

  1. Alprazolam Reduces Inflammatory Cytokine Production in Pancreatic Cancer-Associated Fibroblasts. Co-author DOI 10.1158/2767-9764.crc-25-0472↗
  2. A targetable opioid/cancer associated fibroblast axis drives extracellular matrix remodeling and tumor aggressiveness in pancreatic cancer Co-author DOI 10.64898/2026.05.20.726559↗
  3. CPSF3 inhibition blocks pancreatic cancer cell proliferation through disruption of core histone mRNA processing. Co-author DOI 10.1261/rna.079931.123↗
  4. Lorazepam Stimulates IL6 Production and Is Associated with Poor Survival Outcomes in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-23-0547↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michael E. Feigin · 4 shared papers, 2023–2026 · strength 0.83
  2. Hunter D. Reavis · 2 shared papers, 2026 · strength 0.51
  3. Nina G. Steele · 2 shared papers, 2023–2026 · strength 0.38
  4. Janusz Franco‐Barraza · 2 shared papers, 2023–2026 · strength 0.38
  5. Edna Cukierman · 2 shared papers, 2023–2026 · strength 0.38
  6. Abigail C. Cornwell · 2 shared papers, 2023–2024 · strength 0.33
  7. Swati Venkat · 2 shared papers, 2023–2024 · strength 0.33
  8. Abdulrahman A. Alahmari · 2 shared papers, 2023–2024 · strength 0.33
  9. Joao A Paulo · 1 shared paper, 2026 · strength 0.27
  10. Brooke Pereira · 1 shared paper, 2026 · strength 0.24
  11. Paul Timpson · 1 shared paper, 2026 · strength 0.24
  12. Katerina V. Gurova · 1 shared paper, 2024 · strength 0.18
  13. Christos K Fountzilas · 1 shared paper, 2023 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.